Merck & Co. CEO Kenneth Frazier's 2021 pay falls 31% to $15M
Merck & Co. reports 2021 executive compensation
By ExecPay News
Published: April 4, 2022
Merck & Co. reported fiscal year 2021 executive compensation information on April 4, 2022.
In 2021, six executives at Merck & Co. received on average a compensation package of $9.2M, a 36% decrease compared to previous year.
Average pay of disclosed executives at Merck & Co.
Kenneth C. Frazier, Chief Executive Officer, received $15M in total, which decreased by 31% compared to 2020. 49% of Frazier's compensation, or $7.4M, was in stock awards. Frazier also received $2.8M in non-equity incentive plan, $3.2M in option awards, $1.5M in salary, as well as $299K in other compensation.
For fiscal year 2021, the median employee pay was $102,803 at Merck & Co.. Therefore, the ratio of Kenneth C. Frazier's pay to the median employee pay was 148 to one.
Robert M. Davis, Chief Executive Officer, received a compensation package of $14M, which increased by 101% compared to previous year. 46% of the compensation package, or $6.3M, was in stock awards.
Frank Clyburn, Former Executive Vice President and President, Human Health, earned $9.9M in 2021.
Richard R. DeLuca, Jr, Executive Vice President and President, Merck Animal Health, received $6.8M in 2021.
Dean Li, Executive Vice President and President, Merck Research Laboratories, earned $5.5M in 2021.
Caroline Litchfield, Chief Financial Officer, received $4.2M in 2021.
Related executives
Robert Davis
Merck & Co.
Chief Executive Officer
Kenneth Frazier
Merck & Co.
Chief Executive Officer
Caroline Litchfield
Merck & Co.
Chief Financial Officer
Frank Clyburn
Merck & Co.
Former Executive Vice President and President, Human Health
Richard DeLuca
Merck & Co.
Executive Vice President and President, Merck Animal Health
Dean Li
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
You may also like
Source: SEC filing on April 4, 2022.